天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

5-amino-7-(1-naphthyl)-2-(1-naphthylmethylene)-3-oxo-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile

5-amino-7-(1-naphthyl)-2-(1-naphthylmethylene)-3-oxo-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile Struktur
154365-93-2
CAS-Nr.
154365-93-2
Englisch Name:
5-amino-7-(1-naphthyl)-2-(1-naphthylmethylene)-3-oxo-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile
Synonyma:
5-amino-7-(1-naphthyl)-2-(1-naphthylmethylene)-3-oxo-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile;7H-Thiazolo[3,2-a]pyridine-6,8-dicarbonitrile, 5-amino-2,3-dihydro-7-(1-naphthalenyl)-2-(1-naphthalenylmethylene)-3-oxo-
CBNumber:
CB11896452
Summenformel:
C30H18N4OS
Molgewicht:
482.56
MOL-Datei:
154365-93-2.mol

5-amino-7-(1-naphthyl)-2-(1-naphthylmethylene)-3-oxo-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile Eigenschaften

Sicherheit

5-amino-7-(1-naphthyl)-2-(1-naphthylmethylene)-3-oxo-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile Chemische Eigenschaften,Einsatz,Produktion Methoden

5-amino-7-(1-naphthyl)-2-(1-naphthylmethylene)-3-oxo-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

5-amino-7-(1-naphthyl)-2-(1-naphthylmethylene)-3-oxo-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 3)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6349 50
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6176 60
Specs --
 info@specs.net The Netherlands 6833 70
  • 5-amino-7-(1-naphthyl)-2-(1-naphthylmethylene)-3-oxo-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyridine-6,8-dicarbonitrile
  • 7H-Thiazolo[3,2-a]pyridine-6,8-dicarbonitrile, 5-amino-2,3-dihydro-7-(1-naphthalenyl)-2-(1-naphthalenylmethylene)-3-oxo-
  • 154365-93-2
  • C30H18N4OS
Copyright 2019 ? ChemicalBook. All rights reserved